Prenatal management of fetal alloimmune thrombocytopenia.
D000017:ABO Blood-Group System / Q000276:immunology; D016824:Antigens, Human Platelet / Q000032:analysis / Q000276:immunology*; D001805:Blood Transfusion, Intrauterine; D005260:Female; D005312:Fetal Blood / Q000166:cytology; D005315:Fetal Diseases / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D006648:Histocompatibility; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D015994:Incidence; D039661:Integrin beta3; D007518:Isoantibodies / Q000276:immunology*; D008403:Mass Screening; D010976:Platelet Count; D017713:Platelet Transfusion; D011247:Pregnancy; D012307:Risk Factors; D013921:Thrombocytopenia / Q000196:embryology / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*
D000017:ABO Blood-Group System; D016824:Antigens, Human Platelet; C061248:ITGB3 protein, human; D016756:Immunoglobulins, Intravenous; D039661:Integrin beta3; D007518:Isoantibodies